House Democrats ask pharma CEOs to explain insulin pricing

House Democrats Wednesday asked Eli Lilly and Co. (NYSE:LLY), Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) and Sanofi (NASDAQ:SNY; Euronext:SAN) to justify all insulin product price increases over the past decade and disclose any deals that may have inhibited generic

Read the full 399 word article

User Sign In